Surface-bound heparin fails to reduce thrombin formation during clinical cardiopulmonary bypass

Journal of Thoracic and Cardiovascular Surgery

Volumn 111, Issue 1, 1996, Pages 1-12

  Gorman, R C ^a   Ziats, N P ^a   Rao, A K ^a   Gikakis, N ^a   Sun, L ^a   Khan, M M H ^a   Stenach, N ^a   Sapatnekar, S ^a   Chouhan, V ^a   Gorman III, J H ^a   Niewiarowski, S ^a   Colman, R W ^a   Anderson, J M ^a   Edmunds Jr , L H ^a   Khuri, S F ^a   Magovern, G J ^a   Hill, R C ^a   Von Segesser, L K ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; ALPHA 2 ANTIPLASMIN; ANTITHROMBIN; BETA THROMBOGLOBULIN; COMPLEMENT COMPONENT C3B; FIBRINOPEPTIDE A; HEPARIN; LEUKOCYTE ELASTASE; PLASMIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTAMINE; PROTHROMBIN; THROMBIN; TISSUE PLASMINOGEN ACTIVATOR; WARFARIN;

ADULT; AORTA VALVE REPLACEMENT; ARTICLE; BLOOD CLOTTING TIME; BLOOD SAMPLING; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; EXTRACORPOREAL CIRCULATION; FEMALE; HEART MUSCLE REVASCULARIZATION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; MITRAL VALVE REPLACEMENT; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION; THROMBOCYTE COUNT;

EID: 9044236523     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5223(96)70395-1     Document Type: Article

References (54)

1. MD Boisclair DA Lane H Philippou S Sheikh B Hunt Thrombin production, inactivation and expression during open heart surgery measured by assays for activation fragments including a new ELISA for prothrombin Fragment F1+2 Thromb Haemost 70 1993 253 258
2. SJ Brister FA Ofosu MR Buchanan Thrombin generation during cardiac surgery: Is heparin the ideal anticoagulant? Thromb Haemost 70 1993 259 262
3. MA Shuman Thrombin-cellular interactions Ann NY Acad Sci 485 1986 228 239
4. SR Coughlin T-KH Vu DT Hung VI Wheaton Characterization of a functional thrombin receptor J Clin Invest 89 1992 351 355
5. EG Levin U Marzec J Anderson LA Harker Thrombin stimulates tissue plasminogen activator release from cultured human endothelial cells J Clin Invest 74 1984 1988 1995
6. V Videm JL Svennevig E Fosse G Semb A Osterud TE Mollines Reduced complement activation with heparin-coated oxygenator and tubings in coronary bypass operations J Thorac Cardiovasc Surg 103 1992 806 813
7. YJ Gu W van Oeveren C Akkerman PW Boonstra RJ Huyzen CRH Wildevuur Heparin-coated circuits reduce the inflammatory response to cardiopulmonary bypass Ann Thorac Surg 55 1993 917 922
8. V Videm TE Mollnes P Garred JL Svennevig Biocompatibility of extracorporeal circulation J Thorac Cardiovasc Surg 101 1991 654 660
9. M Pekna L Hagman E Halden UR Nilsson B Nilsson S Thelin Complement activation during cardiopulmonary bypass: effects of immobilized heparin Ann Thorac Surg 58 1994 421 424
10. PW Boonstra YJ Gu C Akkerman J Haan R Huyzen W van Oeveren Heparin coating of an extracorporeal circuit partly improves hemostasis after cardiopulmonary bypass J Thorac Cardiovasc Surg 107 1994 289 292
11. Korn RL, Fisher CA, Stenach N, et al. The effects of Carmeda Bioactive Surface (CBAS) on human blood components during simulated extracorporeal circulation. J Thorac Cardiovasc Surg [In press].
12. J Borowiec S Thelin L Bagge J Hultman H-E Hansson Decreased blood loss after cardiopulmonary bypass using heparin-coated circuit and 50% reduction of heparin dose Scand J Thorac Cardiovasc Surg 26 1992 177 185
13. LK von Segesser BM Weiss E Garcia MI Turina Risk and benefit of low systemic heparinization during open heart surgery Ann Thorac Surg 58 1994 391 398
14. O Larm R Larsson P Olsson A new non-thrombogenic surface prepared by selective covalent binding of heparin via a modified reducing terminal residue Biomat Med Device Artif Organs 11 1983 161 173
15. NP Ziats DA Pankowsky BP Tierney OD Ratnoff JM Anderson Adsorption of Hageman factor (factor XII) and other human plasma proteins to biomedical polymers J Lab Clin Med 116 1990 687 696
16. ACA Carvalho RW Colman RS Lees Platelet function in hyperlipoproteinemia N Engl J Med 290 1974 434 438
17. V Rucinski S Niewiarowski DA Walz AZ Budzynski Antiheparin proteins secreted by human platelets; purification, characterization and radioimmunoassay Blood 53 1979 47 62
18. YT Wachtfogel U Kucich J Greenplate Human neutrophil degranulation during extracorporeal circulation Blood 69 1987 324 330
19. JD Tamerius MK Pangburn HJ Muller-Eberhard Detection of a neoantigen on human C3bi and C3d by monoclonal antibody J Immunol 135 1985 2015 2019
20. J Amiral JM Walenga J Fareed Development and performance characteristics of a competitive enzyme immunoassay for fibrinopeptide A Semin Thromb Hemost 10 1984 228 242
21. DB Rylatt AS Blake LE Cottlis An immunoassay for human D-dimer using monoclonal antibodies Thromb Res 31 1983 767 778
22. H Pelzer Schwarz W Stuber Determination of human prothrombin activation fragment 1+2 in plasma with an antibody against synthetic peptide Thromb Haemost 65 1991 153 164
23. H Pelzer A Schwarz N Heimberger Determination of human thrombin-antithrombin III complex in plasma with an enzyme-linked immunosorbent assay Thromb Haemost 59 1988 101 106
24. N Bergsdorf T Nilsson P Wallen An enzyme-linked immunosorbent assay for determination of tissue plasminogen activator applied to patients with thromboembolic disease Thromb Haemost 50 1993 740 744
25. PJ Declerck MC Allessi M Verstreken EKO Krithhof I Juhan-Vague D Collen Measurement of plasminogen activator inhibitor-1 in biological fluids with murine monoclonal antibody-based enzyme- linked immunosorbent assay Blood 71 1988 220 225
26. 2 antiplasmin complex in human plasma—application to the detection of in vivo activation of the fibrinolytic system Thromb Haemost 56 1986 124 127
27. WR Wagner PC Johnson KA Thompson GC Marrone Heparin-coated cardiopulmonary bypass circuits: hemostatic alterations and postoperative blood loss Ann Thorac Surg 58 1994 734 741
28. Hsu L-C, Tong SD. United States Patent 4,871,357.
29. AT Cheung SK Levin SJ Weiss MA Acker N Stenach Intracardiac thrombus: a risk of incomplete anticoagulation for cardiac operations Ann Thorac Surg 58 1994 541 542
30. K Kodama B Pasche P Olsson J Swedenborg L Adolfsson O Larm J Riesenfeld Antithrombin III binding to surface immobilized heparin and its relation to F Xa inhibition Thromb Haemost 58 1987 1064 1067
31. G Elgue M Blomback P Olsson J Riesenfeld On the mechanism of coagulation inhibition on surfaces with end point immobilized heparin Thromb Haemost 70 1993 289 293
32. YJ Gu W van Oeveren KWHJ van der Kamp C Akkerman PW Boonstra CRH Wildevuur Heparin-coating of extracorporeal circuits reduces thrombin formation in patients undergoing cardiopulmonary bypass Perfusion 6 1991 221 225
33. MJ Pradhan JS Fleming UU Nkere J Arnold CRH Wildevuur KM Taylor Clinical experience with heparin-coated cardiopulmonary bypass circuits Perfusion 6 1991 235 242
34. LH Edmunds Jr. Surface-bound heparin—panacea or peril Ann Thorac Surg 58 1994 285 286
35. JN Lindon EW Salzman EW Merrill Catalytic activity and platelet reactivity of heparin covalently bonded to surfaces J Lab Clin Med 105 1985 219 226
36. V Videm L Nilsson P Venge HL Svennevig Reduced granulocyte activation with a heparin-coated device in an in vitro model of cardiopulmonary bypass Artif Organs 15 1991 90 95
37. J Borowiec S Thelin L Bagge L Nilsson P Venge HE Hansson Heparin-coated circuits reduce activation of granulocytes during cardiopulmonary bypass J Thorac Cardiovasc Surg 104 1992 642 647
38. E Fosse O Moen E Johnson Reduced complement and granulocyte activation with heparin-coated cardiopulmonary bypass Ann Thorac Surg 58 1994 472 477
39. SW Downing LH Edmunds Jr Release of vasoactive substances during cardioplumonary bypass Ann Thorac Surg 54 1992 1236 1243
40. EH Blackstone JW Kirklin RW Stewart DE Chenoweth The damaging effects of cardiopulmonary bypass KK Wu EC Roxy Prostaglandins in clinical medicine: cardiovascular and thrombotic disorders 1982 Year Book Chicago 355 369
41. RD Dowling ME Brown RO Whittington JJ Quinlan JM Armitage Clinical cardiopulmonary bypass without systemic anticoagulation Ann Thorac Surg 56 1993 1176 1178
42. R Rossaint K Slama K Lewandowski Major thoracic surgery during long-term extracorporeal lung assist for treatment of severe adult respiratory distress syndrome (ARDS) Eur J Cardiothorac Surg 6 1992 43 45
43. SF Aranki DH Adams RJ Rizzo Femoral veno-arterial extracorporeal life support with minimal or no heparin Ann Thorac Surg 56 1993 149 155
44. S Chaiyaroj M Couyant P Angelopoulos J Tatoulis Cardiac surgery with low systemic heparinisation using a heparin-bonded tubing circuit Aust Assoc J Cardiac Surg 2 1993 30 31
45. YT Wachtfogel PC Harpel LH Edmunds Jr RW Colman Formation of C1s-C1-inhibitor, kallikrien-C1-inhibitor and plasmin-alpha 2- plasmin inhibitor complexes during cardiopulmonary bypass Blood 73 1989 468 471
46. LM Pang SA Stalcup JS Lipset CJ Hayes FO Bowman RB Mellins Increased circulating bradykinin during hypothermia and cardiopulmonary bypass in children Circulation 60 1979 1503 1507
47. Sundaram S, Hack CE, Niewiarowski S, et al. Nafamostat mesilate, a broad spectrum protease inhibitor, modulates cellular and humoral activation in simulated extracorporeal circulation. Thromb Haemost [In press].
48. MD Boisclair DA Lane H Philippou Mechanisms of thrombin generation during surgery and cardiopulmonary bypass Blood 82 1993 3350 3357
49. N Tabuchi J de Haan PW Boonstra W van Oeveren Activation of fibrinolysis in the pericardial cavity during cardiopulmonary bypass J Thorac Cardiovasc Surg 106 1993 828 833
50. Chung JH, Gikakis N, Rao AK, Drake TA, Colman RW, Edmunds LH Jr. Pericardial blood activates the extrinsic pathway during clinical cardiopulmonary bypass. Circulation [In press].
51. Khuri S, Valeri CR, Loscalzo J, et al. Heparin causes platelet dysfunction and increases fibrinolysis before the institution of cardiopulmonary bypass. Ann Thorac Surg [In press].
52. EW Salzman RD Rosenberg MH Smith JN Lindon L Favreau Effect of heparin and heparin fractions on platelet aggregation J Clin Invest 65 1980 64 73
53. JK Kirklin DE Chenoweth DC Naftel Effects of protamine administration after cardiopulmonary bypass on complement, blood elements, and the hemodynamic state Ann Thorac Surg 41 1986 193 199
54. RA Pixley A Cassello RA De La Cadena N Kaufman RW Colman Effect of heparin on the activation of factor XII and the contact system in plasma Thromb Haemost 66 1991 540 547